Sustainable microcrystalline cellulose (MCC) for eco-friendly oral care
Harnessing patented AaltoCell technology, this sustainable microcrystalline cellulose (MCC) offers eco-friendly and efficient cleaning for oral care products. It features low nitrate levels, three particle sizes, and ensures gentle, effective tooth cleaning without sharp edges.
Overview
Our sustainable microcrystalline cellulose (MCC) is produced using the innovative AaltoCell technology, offering a versatile ingredient for oral care products like toothpaste and scrubs. This MCC is designed to be both energy-efficient and environmentally friendly, with a commitment to a low carbon footprint. It is sourced from sustainably managed forests in Finland, ensuring the highest quality and purity with minimal environmental impact.
Technical specifications
Key features:
- Eco-friendly production: Utilizes patented AaltoCell technology to ensure low energy consumption and a reduced carbon footprint.
- High purity: Sourced from sustainably managed Finnish forests, resulting in the lowest nitrate levels and high-quality cellulose.
- Particle options: Available in three different particle sizes to suit various product formulations and needs.
- Gentle cleaning: Designed to provide soft cleaning action for oral care products without sharp edges, promoting tooth health.
Technology readiness level
This technology is currently at Technology Readiness Level 2, indicating that it is in the initial phase of development. Future validation efforts include presentations and sample provision for formulation testing.
About Harke pharma
HARKE Pharma is a dedicated division of HARKE UK & Ireland, which operates as a member of the global HARKE GROUP. The division specializes in the distribution of high-quality pharmaceutical and nutraceutical ingredients, including a wide range of excipients and active pharmaceutical ingredients (APIs). Beyond supply, HARKE Pharma provides comprehensive technical support, collaborating with manufacturers on formulation development, optimization of dosage forms, and navigating regulatory requirements. Their portfolio covers applications such as tableting, coatings, capsules, and various liquid and semisolid formulations, supported by expert teams located in Manchester and a distribution hub in Halifax. The company leverages over 50 years of group expertise to facilitate project execution from initial concept to commercialization. By partnering with global suppliers, they assist brands and manufacturers in overcoming technical challenges, such as solubility enhancement, stability improvement, and the implementation of innovative delivery systems. Their services include sourcing specialized raw materials, providing regulatory advice, and assisting with performance and microbiological testing to ensure quality standards are met. By serving as a technical bridge between material producers and formulators, HARKE Pharma plays a critical role in bringing high-performance pharmaceutical products to market across the UK and Ireland.
delivered to your inbox.